Mepivacaine Hydrochloride

Spezifikationen

1722-62-9CAS-Nummer

217-023-9EG-Nummer

N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;hydrochlorideIUPAC-Name

C15H23ClN2OChemische Formel

282.81 g/molMolekulargewicht

Mepivacaine hydrochloride; 1722-62-9; Mepivacaine HCL; Scandicain; Optocain; Scandonest Plain; Polocaine-Mpf; Arestocaine hydrochloride; Mepivacaine Monohydrochloride; ISOCAINE HYDROCHLORIDE; 1-Methyl-2',6'-pipecoloxylidide hydrochloride; 1-Methyl-2',6'-pipecoloxylidide monohydrochloride; 4VFX2L7EM5; NSC-758674; (1-Methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochloride; CHEBI:6760; 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, hydrochloride (1:1); N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride (1:1); Iq Dental Mepivacaine; Scandonest 3% Plain; RefChem:55583; Carbocaine V Sterile Aqueous; POLOCAINE (MEPIVACAINE HCl); Carbocaine-V Sterile Aqueous Solution; (2RS)-N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide monohydrochloride; 217-023-9; N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide hydrochloride; Polocaine; Carbocain; Mepivicaine hydrochloride; MFCD00144738; DTXSID4031566; Mepivacaine (hydrochloride); N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide;hydrochloride; (+-)-1-Methyl-2',6'-pipecoloxylidide monohydrochloride; MLS000028662; Carbocaina; Mepivastesin; Scandonest; Meaverin; 1-Methyl-2',6'-pipecoloxylidine hydrochloride; NCGC00095108-01; Scandinibsa; Chlorocain; SMR000058904; Sabol; Carbocaine hydrochloride; Mepivacaine chlorhydrate; EINECS 217-023-9; Carbocaine monohydrochloride; UNII-4VFX2L7EM5; N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide hydrochloride; 1722-62-9 (HCl); N-(2,6-dimethylphenyl)(1-methyl(2-piperidyl))carboxamide, chloride; SR-01000000263; Mepivacaine hydrochloride [JAN]; Carbocaine (TN); Polocaine (TN); Mepivacaine hydrochloride [USP:JAN]; mepivacain hydrochloride; Scandonest plain (TN); Opera_ID_1165; SCHEMBL34245; Mepivacaine hydrochloride CRS; MLS001074068; MLS001424226; SPECTRUM1504148; HY-B0517AR; orb1310144; 2',6'-Pipecoloxylidide, 1-methyl -, monohydrochloride; CHEMBL1200440; DTXCID2011566; HY-B0517A; (+/-)-Mepivacaine hydrochloride; HMS1922D17; HMS5081O20; Pharmakon1600-01504148; Tox21_111424; CCG-39081; NSC758674; s3155; SBB057000; MEPIVACAINE HYDROCHLORIDE [MI]; AKOS015889311; Mepivacaine hydrochloride (JP18/USP); AC-2102; CCG-101083; EBC-155051; KS-1271; Mepivacaine (hydrochloride) (Standard); NC00333; NSC 758674; 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-1-methyl-, monohydrochloride, (+-)-; MEPIVACAINE HYDROCHLORIDE [MART.]; MEPIVACAINE HYDROCHLORIDE [VANDF]; NCGC00095108-02; NCGC00095108-03; BM162010; MEPIVACAINE HYDROCHLORIDE [USP-RS]; MEPIVACAINE HYDROCHLORIDE [WHO-DD]; CAS-1722-62-9; M2560; NS00082807; ST50993897; SW197713-3; MEPIVACAINE HYDROCHLORIDE [GREEN BOOK]; A12146; D00738; M06309; MEPIVACAINE HYDROCHLORIDE [EP MONOGRAPH]; MEPIVACAINE HYDROCHLORIDE [ORANGE BOOK]; MEPIVACAINE HYDROCHLORIDE [USP IMPURITY]; EN300-7386486; MEPIVACAINE HYDROCHLORIDE [USP MONOGRAPH]; (+/-)-Mepivacaine hydrochloride, >=98% (HPLC); SR-01000000263-4; Q27107324; (+/-)-1-METHYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE; N-(2,6-DIMETHYLPHENYL)-1-METHYLPIPERIDINE-2-CARBOXAMIDE HCL; Mepivacaine hydrochloride, 98.0-102.0%, meets USP testing specifications; Mepivacaine hydrochloride, European Pharmacopoeia (EP) Reference Standard; N-(2,6-dimethylphenyl)-1-methyl-piperidine-2-carboxamide;hydrochloride; Mepivacaine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Mepivacaine hydrochloride, United States Pharmacopeia (USP) Reference Standard; N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide--hydrogen chloride (1/1); 2-PIPERIDINECARBOXAMIDE, N-(2,6-DIMETHYLPHENYL)-1-METHYL-, MONOHYDROCHLORIDE, (+/-)-Synonyme